Kimberly McClintock has been appointed executive vice president at Metrics Contract Services, the company’s contract pharmaceutical development and manufacturing division. 

McClintock has extensive experience in leading and growing pharmaceutical CDMOs, with expertise in research and development, project management, sales and business development. 

John Ross, president of Mayne Pharma USA and former executive vice president at Metrics Contract Services, said, “Kim McClintock joins the organization at an exciting time when it is poised to open in early 2018 a new $80-million solid oral dose manufacturing facility in Greenville, N.C. Kim is a dynamic leader with an engaging and inclusive management style and is well positioned to guide Metrics Contract Services through this next phase of growth.” 

Prior to joining the company, Ms. McClintock served as senior director and business team lead for Alcami Corp., where she led the drug product development, manufacturing and lab testing services business unit.

Mayne Pharma is investing $80 million in a new 126,000-sq.-ft., oral-dose commercial manufacturing facility that will quadruple the company’s U.S. manufacturing capacity. The company will also dedicate more than 10 new manufacturing suites and analytical labs for pre-commercial activities, more than doubling current development and clinical capacity.